OverviewSuggest Edit

MediWound is a biotechnology company. It is focused on developing, manufacturing and globally commercializing products that address unmet needs in the fields of burn and chronic wound management. MediWound's aim is to provide healthcare professionals and patients with its burn wound eschar removal agent NexoBrid.


Latest Updates

Employees (est.) (Sep 2019)73
Share Price (Oct 2019)$3 (-1%)

MediWound Financials and Metrics

MediWound Revenue

Market capitalization (15-Oct-2019)


Closing stock price (15-Oct-2019)

MediWound's current market capitalization is $80.7 m.
Show all financial metrics

MediWound Online and Social Media Presence

Embed Graph

MediWound Frequently Asked Questions

  • When was MediWound founded?

    MediWound was founded in 2001.

  • How many employees does MediWound have?

    MediWound has 73 employees.